244 related articles for article (PubMed ID: 31418375)
21. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
[TBL] [Abstract][Full Text] [Related]
22. [The prognostic value of baseline serum free light chain in immunoglobulin light-chain cardiac amyloidosis].
Wang LM; Wang TT; Tian Y; Zhao L; Yang XC; Chen WM
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):47-53. PubMed ID: 32023754
[No Abstract] [Full Text] [Related]
23. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
24. [Value of Serum Light Chain in Diagnosis and Evaluation of Efficacy for Multiple Myeloma].
Yu Y; Teng XJ; Luo GL; Wu LX; Guo BQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):886-893. PubMed ID: 32552953
[TBL] [Abstract][Full Text] [Related]
25. Serum free light chain response after 2 courses of induction chemotherapy predicts prognosis in myeloma patients.
Yağcı M; Karakaya F; Suyanı E; Haznedar R
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):98-102. PubMed ID: 25441109
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of serum free light chain in patients with multiple myeloma].
Zhang SS; Wu S; Qu XY; Xu J; Liu P; Lu H; Wu HX; Xu JR; Li JY; Chen LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):930-5. PubMed ID: 23998588
[TBL] [Abstract][Full Text] [Related]
27. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease.
Molina-Andújar A; Robles P; Cibeira MT; Montagud-Marrahi E; Guillen E; Xipell M; Blasco M; Poch E; Rosiñol L; Bladé J; Quintana LF
BMC Nephrol; 2020 Mar; 21(1):111. PubMed ID: 32234026
[TBL] [Abstract][Full Text] [Related]
28. Serum Free Light Chain Predict Overall Survival and Response to Therapy in Patients with Newly Diagnosed Multiple Myeloma.
Meddour Y; Rahali MC; Belakehal SE; Ardjoun FZ; Chaib S; Djidjik R
Clin Lab; 2018 Apr; 64(4):551-558. PubMed ID: 29739080
[TBL] [Abstract][Full Text] [Related]
29. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma.
Iwama K; Chihara D; Tsuda K; Ugai T; Sugihara H; Nishida Y; Yamakura M; Takeuchi M; Matsue K
Eur J Haematol; 2013 Feb; 90(2):134-41. PubMed ID: 23210517
[TBL] [Abstract][Full Text] [Related]
30. Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties.
Fabbrini P; Sirtori S; Casiraghi E; Pieruzzi F; Genovesi S; Corti D; Brivio R; Gregorini G; Como G; Carati ML; Viganò MR; Stella A
Blood Purif; 2013; 35 Suppl 2():52-8. PubMed ID: 23676837
[TBL] [Abstract][Full Text] [Related]
31. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease.
Martín-Nares E; Saavedra-González V; Fagundo-Sierra R; Santinelli-Núñez BE; Romero-Maceda T; Calderón-Vasquez K; Hernandez-Molina G
Sci Rep; 2021 Jan; 11(1):1832. PubMed ID: 33469111
[TBL] [Abstract][Full Text] [Related]
32. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
Nelson M; Brown RD; Gibson J; Joshua DE
Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between Expression of CD200 and Regulatory T Cells in Multiple Myeloma and Its Significance in Prognostic Stratification].
Zhu MX; Wan WL; Li HS; Wang YF; Wang J; Ling HS; Yan XX; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1427-1432. PubMed ID: 27784369
[TBL] [Abstract][Full Text] [Related]
35. Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype.
Scarpa R; Pulvirenti F; Pecoraro A; Vultaggio A; Marasco C; Ria R; Altinier S; Compagno N; Firinu D; Plebani M; De Carli M; Matucci A; Vianello F; Vacca A; Spadaro G; Quinti I; Agostini C; Milito C; Cinetto F
Front Immunol; 2020; 11():319. PubMed ID: 32296413
[TBL] [Abstract][Full Text] [Related]
36. [The diagnostic and prognostic values of serum free light chain in patients with primary light chain amyloidosis].
Zhang CL; Feng J; Shen KN; Su W; Zhang CL; Huang XF; Cao XX; Zhang L; Zhou DB; Li J
Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):942-945. PubMed ID: 27995877
[TBL] [Abstract][Full Text] [Related]
37. Automated alarm to detect antigen excess in serum free immunoglobulin light chain kappa and lambda assays.
Urdal P; Amundsen EK; Toska K; Klingenberg O
Scand J Clin Lab Invest; 2014 Oct; 74(7):575-81. PubMed ID: 25007050
[TBL] [Abstract][Full Text] [Related]
38. Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests.
Kubicki T; Dytfeld D; Baszczuk A; Wysocka E; Komarnicki M; Lewandowski K
Postepy Hig Med Dosw (Online); 2017 Jan; 71(0):40-46. PubMed ID: 28181910
[TBL] [Abstract][Full Text] [Related]
39. Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test.
Heaney JLJ; Campbell JP; Yadav P; Griffin AE; Shemar M; Pinney JH; Drayson MT
BMC Nephrol; 2017 Jul; 18(1):247. PubMed ID: 28728609
[TBL] [Abstract][Full Text] [Related]
40. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.
Morabito F; De Filippi R; Laurenti L; Zirlik K; Recchia AG; Gentile M; Morelli E; Vigna E; Gigliotti V; Calemma R; Amoroso B; Neri A; Cutrona G; Ferrarini M; Molica S; Del Poeta G; Tripodo C; Pinto A
Blood; 2011 Dec; 118(24):6353-61. PubMed ID: 21998207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
